Two endogenous retroviral loci appear to contribute to Multiple Sclerosis

Citations of this article
Mendeley users who have this article in their library.

This article is free to access.


Background: Two endogenous retroviral loci seem to be involved in the human disease Multiple sclerosis (MS). Results: The two retroviral loci synergize in and contribute to MS (shown by ANOVA). Synergy probably means recombination or complementation of the activated viruses. Similar observations may be true for Type 1 Diabetes and Rheumatoid arthritis. In MS the genes also synergize with the immune system; this could well be a common phenomenon. Conclusion: We formulate various theories about the role of the viruses. Also, the concept is developing that some forms of autoimmunity should be treatable with antiretrovirals. In the case of MS, this idea is gradually gaining weight.




Nexø, B. A., Jensen, S. B., Nissen, K. K., Hansen, B., & Laska, M. J. (2016). Two endogenous retroviral loci appear to contribute to Multiple Sclerosis. BMC Neurology. BioMed Central Ltd.

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free